Arcus Biosciences, Inc.
RCUS· NYSE
RCUSArcus Biosciences, Inc.
Filed May 9, 2018 · 10-Q · 39 days after period end · 0001564590-18-012447
| Metric | Q1 2018 | Q1 2017 |
|---|---|---|
| Revenue | $1.25M | — |
| Net Income | -$12.95M | -$7.20M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Arcus Biosciences, Inc. · CIK 1724521 · Engraved from SEC EDGAR
ended Mar 31, 2018 · filed May 9, 2018 · 39 d after period end
